PMPhilip Morris International exhibits strong fundamental performance with consistent profitability and a significant dividend yield, aligned with defensive sector characteristics. However, recent technical indicators suggest a short-term bearish trend, and future growth may be influenced by the transition to smoke-free products and evolving regulations.
PMI is navigating a significant industry shift towards smoke-free alternatives, which presents both growth opportunities and regulatory risks. Its exposure to wellness and healthcare products is a nascent positive thematic. The company is well-positioned in established markets but faces challenges in adapting to changing consumer preferences and regulatory landscapes.
PMI demonstrates robust profitability, strong cash flow generation, and a consistent dividend payout. Its financial position is solid, though the latest reported quarter showed a negative net margin, which warrants attention. The company maintains a significant debt load but appears well-covered by its earnings and cash flow.
The stock has experienced a significant decline over the past month and 5 days, with price trading below key moving averages. Momentum indicators are mixed but lean towards bearish, suggesting potential for further downside or a period of consolidation before any significant recovery.
| Factor | Score |
|---|---|
| Transition to Smoke-Free Products | 80 |
| ESG & Sustainability | 65 |
| Regulatory Environment | 50 |
| Market Dominance & Diversification | 70 |
| Wellness and Healthcare Products | 55 |
| Factor | Score |
|---|---|
| Valuation | 40 |
| Profitability | 85 |
| Growth | 70 |
| Balance Sheet Health | 30 |
| Cash Flow | 90 |
| Dividend Yield | 95 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 35 |
| Volume Confirmation | 40 |
| Support & Resistance | 50 |
| Short-term Performance | 20 |
Consistent EPS Beats
The company has exceeded earnings per share (EPS) estimates for the last 5 consecutive quarters, demonstrating consistent operational efficiency and better-than-expected profitability.
Strong Free Cash Flow Generation
Free cash flow has shown a positive trend, increasing from $7.88 billion in Q4 2023 to $10.77 billion in Q4 2024, indicating robust cash generation capabilities to fund operations, investments, and shareholder returns.
Q4 2024 Revenue Miss
The company reported a net loss of -$579 million on revenue of $9.706 billion in Q4 2024, missing analyst expectations and indicating recent operational challenges.
High P/S Ratio
The Price-to-Sales (P/S) ratio of 8.7 (TTM) is relatively high, suggesting that investors are paying a premium for each dollar of sales, which could lead to price corrections if sales growth falters.
June 2025
27
Ex-Dividend Date
July 2025
15
Next Dividend Date
October 2025
21
Next Earnings Date
H: $2.14
A: $2.11
L: $2.07
H: 10.84B
A: 10.68B
L: 10.48B
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.
184.09 USD
The 39 analysts offering 1 year price forecasts for PM have a max estimate of 225.00 and a min estimate of 143.45.